Biosensors - DL Stock (B20) - Price and Fundamental Data | DZHI - DZH International
Biosensors - DL (B20)

Company Info and Fundamentals

Principal Activities
Biosensors International Group Limited develops, manufactures and commercialises innovative medical devices used in interventional cardiology and critical care procedures. Biosensors manufactures and markets critical care catheter systems and related devices that are used during heart surgery and intensive care treatment and monitoring. In the year 2000, the Group entered the interventional cardiology market with the introduction of their proprietary coronary bare-metal stent, along with stent delivery balloon catheter system, followed by an expansion of the product line to include angioplasty balloons and catheters. The Group has internally developed technology to address each component of a drug-eluting stent system, including a stent,, a stent delivery catheter, a polymer and a proprietary drug. The Group is pursuing two drug-eluting stent programs independently, and has licensed aspects of its drug-eluting stent technology to four licensees.
The Group has offices in Newport Beach, California, The Netherlands, Switzerland, Singapore and Japan. Biosensors also has the manufacturing operations in Singapore and The Netherlands.
Full NameBiosensors International Group LimitedStock NoB20
ExchangeSingapore Exchange (SGX)BoardMain board
ISIN CodeYear-End31-Mar
Exchange SectorManufacturingSub Sector1
Par Value (USD)0.0070Issued Shares (Mil)1101.4360
Paid-Up Cap. (USD Mil)0.0730Market Capitalization (Mil)914.1919
Share Price (SGD)
Current Price0.00
Previous Close0.83
Week High0.84
Week Low0.82
Month High0.84
Month Low0.82
52-week High0.85
52-week Low0.64
Share Price Performance(%)
MTD change-100.0000
YTD change-100.0000
Today Volume('000)0
100-day Average Daily Volume ('000)4,951.77
Technical Indicators-A shapshot
100-day Moving average0.81
Ratio (Daily)
Dividend Yield0.00
P/E ratio-6.25

Financial Ratios
Exchange Rate*---
Profitability Ratio
Return on Equity-22.1623.2399.258
Return on Revenue-72.89912.53434.368
Liquidity Ratio
Return on Equity6.5496.05912.672
Return on Revenue6.1355.59411.966
Gross Eps (cents) *-13.2902.3806.710
Dividend (cents) *0.0002.0000.000
Net tangible asset0.005-0.000-0.001
Price to cash flow ratio0.0000.0000.000
Cash for per share568.641429.3851,067.302
Price to book ratio0.0000.0000.000
* Calculation is based on the specific Currency Exchange Rate
Financial Ratios
2016 Q12015 Q42015 Q32015 Q2
Exchange Rate*----
Profitability Ratio
Return on Equity0.919-22.1621.7541.169
Return on Revenue14.118-72.8999.5639.545
Liquidity Ratio
Return on Equity6.8846.5496.2005.875
Return on Revenue6.4486.1355.7745.456
Gross Eps (cents) *0.560-13.2901.3100.870
Dividend (cents) *0.0000.0000.0000.000
Net tangible asset0.0030.005-0.001-0.001
Price to cash flow ratio0.0000.0000.0000.000
Cash for per share147.752569.171377.137257.530
Price to book ratio0.0000.0000.0000.000
* Calculation is based on the specific Currency Exchange Rate
No Data Avaliable